Form 4: Amphastar Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Senior EVP Rong Zhou disposed of 1,354 shares of Amphastar Pharmaceuticals to cover tax liabilities related to vesting restricted stock units.
Summary
- On March 6, 2025, Rong Zhou, Senior EVP of Production Center at Amphastar Pharmaceuticals, Inc., disposed of 1,354 shares of common stock.
- The transaction was executed to cover tax liabilities associated with the vesting of restricted stock units (RSUs).
- The shares were sold at a price of $28.32 per share.
- Following the transaction, Zhou directly owns 115,994 shares and indirectly owns 99,668 shares through the Zhou Family Trust and 5,000 shares held by their spouse.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like executives and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of transaction: Rong Zhou disposed of shares to cover tax liabilities. |
| 03/10/2025 | Date of signature by power of attorney. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.